TAMPA, Fla. & MINNEAPOLIS, Minn.--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI), today announced that Biovest is scheduled to present at the MD Becker Partners Cancer Immunotherapy Conference at the New York Academy of Medicine on October 6th. The presentation will be webcast with the live and archived versions of the broadcast available at the Media Center on Biovest’s corporate website.
